Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dr. Reddy's Laboratories Ltd. ADR sell Jefferies Financial Group Inc.

Start price
€62.50
11.01.24 / 50%
Target price
-
11.01.25
Performance (%)
-76.16%
End price
€14.90
12.01.25
Summary
This prediction ended on 12.01.25 with a price of €14.90. The SELL prediction by Jefferies_Financial_ for Dr. Reddy's Laboratories Ltd. ADR performed very well with a performance of -76.16%. Dividends of €0.44 are taken into consideration when calculating the performance. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Dr. Reddy's Laboratories Ltd. ADR -0.847% -0.847% -13.333%
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

Comments by Jefferies_Financial_ for this prediction

In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren

Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to an "underperform" rating.
Ratings data for RDY provided by MarketBeat

In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Prediction Sell
Perf. (%) -76.16%
Target price
Change
Ends at 11.01.25

Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten